BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 21083619)

  • 1. Effects of Porphyromonas gingivalis infection on human gingival epithelial barrier function in vitro.
    Groeger S; Doman E; Chakraborty T; Meyle J
    Eur J Oral Sci; 2010 Dec; 118(6):582-9. PubMed ID: 21083619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils alter epithelial response to Porphyromonas gingivalis in a gingival crevice model.
    Bondy-Carey JL; Galicia J; Bagaitkar J; Potempa JS; Potempa B; Kinane DF; Veillard F; Scott DA
    Mol Oral Microbiol; 2013 Apr; 28(2):102-13. PubMed ID: 23193955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gingipain-carrying outer membrane vesicles from Porphyromonas gingivalis cause barrier dysfunction of Caco-2 cells by releasing gingipain into the cytosol.
    Nonaka S; Okamoto R; Katsuta Y; Kanetsuki S; Nakanishi H
    Biochem Biophys Res Commun; 2024 May; 707():149783. PubMed ID: 38493746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Microbially-Induced Small Extracellular Vesicles Cross the Blood-Brain Barrier.
    Elashiry M; Carroll A; Yuan J; Liu Y; Hamrick M; Cutler CW; Wang Q; Elsayed R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674094
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell junction remodeling in gingival tissue exposed to a microbial toxin.
    Damek-Poprawa M; Korostoff J; Gill R; DiRienzo JM
    J Dent Res; 2013 Jun; 92(6):518-23. PubMed ID: 23576426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Hesperidin on Barrier Function and Reactive Oxygen Species Production in an Oral Epithelial Cell Model, and on Secretion of Macrophage-Derived Inflammatory Mediators during
    Maquera-Huacho PM; Spolidorio DP; Manthey J; Grenier D
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373533
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-22 Inhibits Apoptosis of Gingival Epithelial Cells Through TGF-β Signaling Pathway During Periodontitis.
    Huang Y; Zhang L; Tan L; Zhang C; Li X; Wang P; Gao L; Zhao C
    Inflammation; 2023 Oct; 46(5):1871-1886. PubMed ID: 37310646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a Berry Polyphenolic Fraction on the Pathogenic Properties of
    Vaillancourt K; Ben Lagha A; Grenier D
    Front Oral Health; 2022; 3():923663. PubMed ID: 35784661
    [No Abstract]   [Full Text] [Related]  

  • 9. Probiotics During the Therapeutic Management of Periodontitis.
    Furlaneto F; Ishikawa KH; Messora MR; Mayer MPA
    Adv Exp Med Biol; 2022; 1373():353-375. PubMed ID: 35612808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phenolic-rich Extract of Cocoa (
    Vaillancourt K; Ben Lagha A; Grenier D
    Front Oral Health; 2022; 3():867793. PubMed ID: 35392377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral, Tongue-Coating Microbiota, and Metabolic Disorders: A Novel Area of Interactive Research.
    Li Y; Cui J; Liu Y; Chen K; Huang L; Liu Y
    Front Cardiovasc Med; 2021; 8():730203. PubMed ID: 34490384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cocoa (Theobroma cacao L.) extract impairs the growth, virulence properties, and inflammatory potential of Fusobacterium nucleatum and improves oral epithelial barrier function.
    Ben Lagha A; Maquera Huacho P; Grenier D
    PLoS One; 2021; 16(5):e0252029. PubMed ID: 34029354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a tart cherry (Prunus cerasus L.) phenolic extract on Porphyromonas gingivalis and its ability to impair the oral epithelial barrier.
    Ben Lagha A; Pellerin G; Vaillancourt K; Grenier D
    PLoS One; 2021; 16(1):e0246194. PubMed ID: 33497417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Dual Zinc plus Arginine formulation attenuates the pathogenic properties of
    Ben Lagha A; Yang Y; Trivedi HM; Masters JG; Grenier D
    J Oral Microbiol; 2020 Aug; 12(1):1798044. PubMed ID: 32944154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1β strengthens the physical barrier in gingival epithelial cells.
    Stolte KN; Pelz C; Yapto CV; Raguse JD; Dommisch H; Danker K
    Tissue Barriers; 2020 Jul; 8(3):1804249. PubMed ID: 32835592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Dimensional
    Tabatabaei F; Moharamzadeh K; Tayebi L
    Tissue Eng Part B Rev; 2020 Oct; 26(5):443-460. PubMed ID: 32131719
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Chen W; Alshaikh A; Kim S; Kim J; Chun C; Mehrazarin S; Lee J; Lux R; Kim RH; Shin KH; Park NH; Walentin K; Schmidt-Ott KM; Kang MK
    J Dent Res; 2019 Sep; 98(10):1150-1158. PubMed ID: 31340691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Mucosal Epithelial Cells.
    Groeger S; Meyle J
    Front Immunol; 2019; 10():208. PubMed ID: 30837987
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral mucosa-on-a-chip to assess layer-specific responses to bacteria and dental materials.
    Rahimi C; Rahimi B; Padova D; Rooholghodos SA; Bienek DR; Luo X; Kaufman G; Raub CB
    Biomicrofluidics; 2018 Sep; 12(5):054106. PubMed ID: 30310527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyromonas gingivalis bypasses epithelial barrier and modulates fibroblastic inflammatory response in an in vitro 3D spheroid model.
    Bugueno IM; Batool F; Keller L; Kuchler-Bopp S; Benkirane-Jessel N; Huck O
    Sci Rep; 2018 Oct; 8(1):14914. PubMed ID: 30297793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.